Shared on04 Aug 25Fair value Decreased 7.70%
Despite a modest improvement in consensus revenue growth forecasts, IDEX's fair value has been revised downward—reflected in a lower analyst price target—amid a notable drop in its expected future P/E multiple. What's in the News IDEX is actively seeking tuck-in M&A opportunities focused on scaling and expanding capabilities in key markets while maintaining organic investments as its top capital allocation priority.
Shared on30 Apr 25Fair value Increased 0.96%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Decreased 1.66%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25Fair value Decreased 4.36%
AnalystConsensusTarget has decreased revenue growth from 5.9% to 5.2%.
Shared on09 Apr 25Fair value Decreased 3.00%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 0.72%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Increased 10%
AnalystConsensusTarget has decreased revenue growth from 7.7% to 6.1%, decreased profit margin from 20.1% to 17.7% and increased future PE multiple from 26.6x to 31.6x.